The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

The pivotal trial for Neurogene's Rett syndrome gene therapy makes use of baseline controls and a rigorous endpoint that ...

I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced publication of the ...

Compass Pathways' Phase 3 COMP-360 data met primary endpoints but disappointed vs analyst expectations. See why investors ...

New trial results reveal zanzalintinib and atezolizumab significantly enhance survival in metastatic colorectal cancer, ...

Results The CO 2 e emissions generated by the trial were 17.65 tonnes. This is equivalent to the emissions generated by driving an average petrol-fueled family car 71 004 km or roughly 1.8 times ...

One year of treatment with dapirolizumab pegol reduced fatigue and disease activity in people with SLE in a Phase 3 trial.

Robin Shackleford, D-Indianapolis, who wrote the clinical trial patient reimbursement bill, said there were plenty of wins for consumers, but some new laws will put people at a disadvantage, such ...

Clinical trial participation often requires a larger time commitment than standard care. But some people find this worthwhile, because the cancer’s progression is monitored more closely ...

His experiment laid the foundation for modern clinical trials—structured studies on humans to assess the safety and effectiveness of treatments, vaccines, or preventive interventions.

CCCC's valuation is unjustifiably low, trading at half its liquidity despite a promising pipeline and no imminent cash crisis. Click here to read my analysis.